Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study
-
Bar-Or, Amit (University of Pennsylvania)
;
Wiendl, Heinz (University of Münster) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Alvarez, Enrique (University of Colorado) ;
Davydovskaya, Maria (Pirogov Russian National Research Medical University) ;
Delgado, Silvia (University of Miami) ;
Evdoshenko, Evgeniy P. (St Petersburg Center for Multiple Sclerosis and Other Autoimmune Diseases) ;
Giedraitiene, Natasa (Vilnius University) ;
Gross-Paju, Katrin (Institute of Health Care Technology) ;
Haldre, Sulev (University of Tartu) ;
Herrman, Craig E. (JWM Neurology) ;
Izquierdo, Guillermo (Hospital Vithas Sevilla) ;
Karelis, Guntis (Riga East University Hospital) ;
Leutmezer, Fritz (Medical University of Vienna) ;
Mares, Miroslav (Pardubice Regional Hospital) ;
Meca-Lallana, Jose Eustasio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Mickeviciene, Dalia (Lithuanian University of Health Sciences) ;
Nicholas, Jacqueline (Riverside Methodist Hospital) ;
Robertson, Derrick S. (University of South Florida) ;
Sazonov, Denis V. (Department of Clinical Trials FSBIH SDMC of FMBA of Russia) ;
Sharlin, Kenneth (Sharlin Health and Neurology) ;
Sundaram, Bharathy (Texas Institute for Neurological Disorders) ;
Totolyan, Natalia (Pavlov First State Medical University of St. Petersburg) ;
Vachova, Marta (Teplice Hospital) ;
Valis, Martin (Charles University) ;
Bagger, Morten (Novartis) ;
Häring, Dieter A. (Novartis) ;
Ludwig, Inga (Novartis) ;
Willi, Roman (Novartis) ;
Zalesak, Martin (Novartis) ;
Su, Wendy (Novartis) ;
Merschhemke, Martin (Novartis) ;
Fox, Edward J. (Central Texas Neurology Consultants PA) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
